...
首页> 外文期刊>Human gene therapy >Coughlan, L.a b , Uusi-Kerttula, H.a c , Ma, J.a , Degg, B.P.a , Parker, A.L.a c , Baker, A.H.a Retargeting adenovirus serotype 48 fiber knob domain by peptide incorporation
【24h】

Coughlan, L.a b , Uusi-Kerttula, H.a c , Ma, J.a , Degg, B.P.a , Parker, A.L.a c , Baker, A.H.a Retargeting adenovirus serotype 48 fiber knob domain by peptide incorporation

机译:Coughlan,L.a b,Uusi-Kerttula,H.a c,Ma,J.a,Degg,B.P.a,Parker,A.L. a c,Baker,A.H.a通过肽掺入重定位腺病毒血清型48纤维瘤结构域

获取原文
获取原文并翻译 | 示例
           

摘要

Adenovirus type 5 (Ad5) is a commonly used vector for gene therapy, but its efficacy is limited by high seroprevalence and off-target hepatic and splenic sequestration. In order to circumvent these limitations, the use of vectors derived from rare species adenoviruses is appealing. The opportunity to retarget rare species vectors to defined cell types through the incorporation of peptide ligands would be advantageous, particularly in targeting tumors and disseminated metastases. We used predictive structural modeling to assess the CD, DG, HI, and IJ loops of the Ad48 fiber knob and identify optimal incorporation locales for the 20-mer peptide, A20FMDV2 (A20). A20FMDV2 targets ανβ6 integrin, which is overexpressed in human carcinomas. Recombinant Ad48 fiber knob proteins Knob48, Knob48-CD-A20, Knob48-DG-A20, Knob48-HI-A20, and Knob48-IJ-A20 were engineered and purified after expression in Escherichia coli. We confirmed that Knob48, Knob48-CD-A20, and Knob48-IJ-A20 formed stable homotrimers. However, Knob48-DG-A20 and Knob-HI-A20 failed to form a trimer. All A20-modified knob proteins blocked the transduction of Ad5-EGFPA20 via ανβ6, demonstrating that the inserted A20 peptide was functional. In conclusion, we show that the CD and IJ loops of Ad48 represent suitable sites for targeting peptide incorporation. Interestingly, in vitro gene transfer mediated by the non-factor-X-binding Ad48 vector was not sensitive to immunoglobulins and complement when incubated in the presence of mouse serum, unlike Ad5. These data support the future generation of the corresponding Ad48 viral vectors, Ad48-CD-A20 and Ad48-IJ-A20, which may offer favorable characteristics for targeted delivery in vivo.
机译:5型腺病毒(Ad5)是基因治疗的常用载体,但其有效性受到高血清阳性率和脱靶肝脾隔离的限制。为了规避这些限制,吸引人的是使用衍生自稀有物种腺病毒的载体。通过掺入肽配体将稀有物种载体重新靶向到确定的细胞类型的机会将是有利的,特别是在靶向肿瘤和扩散的转移瘤方面。我们使用预测性结构建模来评估Ad48纤维瘤的CD,DG,HI和IJ环,并确定20-mer肽A20FMDV2(A20)的最佳掺入位置。 A20FMDV2靶向在人类癌症中过表达的ανβ6整联蛋白。在大肠杆菌中表达后,工程改造并纯化重组Ad48纤维瘤蛋白Knob48,Knob48-CD-A20,Knob48-DG-A20,Knob48-HI-A20和Knob48-IJ-A20。我们确认,Knob48,Knob48-CD-A20和Knob48-IJ-A20形成稳定的均三聚体。但是,Knob48-DG-A20和Knob-HI-A20无法形成三聚体。所有经A20修饰的纽结蛋白均通过ανβ6阻断了Ad5-EGFPA20的转导,表明插入的A20肽具有功能。总之,我们显示Ad48的CD和IJ环代表靶向肽掺入的合适位点。有趣的是,与Ad5不同,当在小鼠血清中孵育时,由非X因子结合的Ad48载体介导的体外基因转移对免疫球蛋白和补体不敏感。这些数据支持了相应的Ad48病毒载体Ad48-CD-A20和Ad48-IJ-A20的下一代,它们可能为体内靶向递送提供有利的特性。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号